Dual signaling of MyD88 and TRIF is critical for maximal TLR4-induced dendritic cell maturation

被引:125
作者
Shen, Hua [1 ]
Tesar, Bethany M. [1 ]
Walker, Wendy E. [1 ]
Goldstein, Daniel R. [1 ]
机构
[1] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA
关键词
D O I
10.4049/jimmunol.181.3.1849
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
TLR4 is a unique TLR because downstream signaling occurs via two separate pathways, as follows: MyD88 and Toll IL-1 receptor (TIR) domain-containing adaptor-inducing IFN-beta (TRIF). In this study, we compared and contrasted the interplay of these pathways between murine dendritic cells (DCs) and macrophages during LPS stimulation. During TLR4 activation, neither pathway on its own was critical for up-regulation of costimulatory molecules in DCs, whereas the up-regulation of costimulatory molecules was largely TRIF dependent in macrophages. LPS-induced secreted factors, of which type I IFNs were one of the active components, played a larger role in promoting the up-regulation of costimulatory molecules in macrophages than DCs. In both cell types, MyD88 and TRIF pathways together accounted for the inflammatory response to LPS activation. Furthermore, signaling of both adaptors allowed maximal T cell priming by LPS-matured DCs, with MyD88 playing a larger role than TRIF. In sum, in our experimental systems, TRIF signaling plays a more important role in LPS-induced macrophage activation than in DC activation.
引用
收藏
页码:1849 / 1858
页数:10
相关论文
共 50 条
[41]   B-cell TLR signaling via MyD88 is not required for antibody maintenance. [J].
Meyer-Bahlburg, Atmut ;
Khim, Socheath ;
Rawlings, David .
CLINICAL IMMUNOLOGY, 2006, 119 :S83-S83
[42]   Expression and significance of the TLR4/MyD88 signaling pathway in ovarian epithelial cancers [J].
Ki Hyung Kim ;
Moo Sung Jo ;
Dong Soo Suh ;
Man Soo Yoon ;
Dong Hun Shin ;
Jeong Hee Lee ;
Kyung Un Choi .
World Journal of Surgical Oncology, 10
[43]   TLR4-Mediated AKT Activation Is MyD88/TRIF Dependent and Critical for Induction of Oxidative Phosphorylation and Mitochondrial Transcription Factor A in Murine Macrophages [J].
Bauerfeld, Christian P. ;
Rastogi, Ruchi ;
Pirockinaite, Gaila ;
Lee, Icksoo ;
Huettemann, Maik ;
Monks, Bobby ;
Birnbaum, Morris J. ;
Franchi, Luigi ;
Nunez, Gabriel ;
Samavati, Lobelia .
JOURNAL OF IMMUNOLOGY, 2012, 188 (06) :2847-2857
[44]   TLR4/MyD88 signaling determines the metastatic potential of breast cancer cells [J].
Wu, Kunlin ;
Zhang, Huihao ;
Fu, Yajuan ;
Zhu, Youzhi ;
Kong, Lingjun ;
Chen, Ling ;
Zhao, Feng ;
Yu, Liangfei ;
Chen, Xiangjin .
MOLECULAR MEDICINE REPORTS, 2018, 18 (03) :3411-3420
[45]   Hyaluronan Signaling during Ozone-Induced Lung Injury Requires TLR4, MyD88, and TIRAP [J].
Li, Zhuowei ;
Potts-Kant, Erin N. ;
Garantziotis, Stavros ;
Foster, W. Michael ;
Hollingsworth, John W. .
PLOS ONE, 2011, 6 (11)
[46]   Heparin alleviates LPS-induced endothelial injury by regulating the TLR4/MyD88 signaling pathway [J].
Liu, Wenxun ;
Li, Yan ;
Wu, Zhaozhao ;
Hai, Kerong ;
Wang, Yun ;
Zhou, Xiaohong ;
Ye, Qingshan .
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 22 (06)
[47]   Dendritic cell expression of MyD88 is required for rotavirus-induced B cell activation [J].
Blutt, Sarah E. ;
Miller, Amber D. ;
Conner, Margaret E. .
JOURNAL OF VIROLOGY, 2025, 99 (05)
[48]   Differential roles of MyD88 and Type I IFNR in dendritic cell maturation in response to Listeria monocytogenes [J].
Brzoza, KL ;
Hiltbold, EM .
FASEB JOURNAL, 2005, 19 (04) :A370-A370
[49]   Anti-β2GPI/β2GPI induced TF and TNF-α expression in monocytes involving both TLR4/MyD88 and TLR4/TRIF signaling pathways [J].
Xie, Hongxiang ;
Zhou, Hong ;
Wang, Haibo ;
Chen, Dongdong ;
Xia, Longfei ;
Wang, Ting ;
Yan, Jinchuan .
MOLECULAR IMMUNOLOGY, 2013, 53 (03) :246-254
[50]   Effects of acupuncture on microglial polarization and the TLR4/TRIF/MyD88 pathway in a rat model of traumatic brain injury [J].
Cao, Lu-Xi ;
Lin, Shu-Jun ;
Zhao, Si-Si ;
Wang, Shi-Qi ;
Zeng, Hai ;
Chen, Wen-An ;
Lin, Zhuo-Wen ;
Chen, Jia-Xu ;
Zhu, Ming-Min ;
Zhang, Yi-Min .
ACUPUNCTURE IN MEDICINE, 2023, 41 (04) :235-245